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Abstract 
 
 
Endoscopy adverse events (AEs), or complications, are a rising concern on the quality of 
endoscopic care, given the technical advances and the crescent complexity of therapeutic 
procedures, over the entire gastrointestinal and bilio-prancreatic tract. In a small percentage, 
not established, there can be real emergency conditions, as perforation, severe bleeding, 
embolization or infection. Distinct variables interfere in its occurrence, although, the 
awareness of the operator for their potential, early recognition, and local organized facilities 
for immediate handling, makes all the difference in the subsequent outcome. This review 
outlines general AEs’ frequencies, important predisposing factors and putative prophylactic 
measures for specific procedures (from conventional endoscopy to endoscopic cholangio-
pancreatography and ultrasonography), with comprehensive approaches to the management 
of emergent bleeding and perforation. 
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Introduction 
 
Both patients and practitioners expect their endoscopy procedures go according to plan. 
However, for several reasons some patients experience complications or, as correctly 
mentioned, adverse events (AEs).
1
 Even though there is substantial literature describing series 
of AEs, well-designed prospective trials and a standardized nomenclature with agreed-on 
definitions are lacking.
1-3
 
Recently an AE was defined as a situation that prevents completion of the planned procedure 
and/or results in admission to hospital, prolongation of existing hospital stay, another 
procedure (needing sedation/anesthesia), or subsequent medical consultation. AEs are distinct 
from incidents, also unplanned events, but that do not interfere with completion of the 
procedure; an example of this includes bleeding that stops spontaneously or with endoscopic 
therapy during the procedure. Concerning the timing, AEs can occur pre-, intra- (from entering 
the preparation area through leaving the endoscopy room), post- (up to 14 days), and late-
procedure (any time after 14 days, usually up to 30 days).
1,2
 
In this manuscript, we will discuss emergent AEs after endoscopic procedures - serious and 
unexpected situations that demands immediate action. Although cardiopulmonary and 
sedation-related events account for more than 50% of the severe morbidity and mortality 
related to gastrointestinal (GI) endoscopy,
4 
 this document will focus only on major AEs related 
to endoscopic equipment direct harm, mainly hemorrhage, perforation, infection and 
embolization. Even though no sufficient consensus exists in most cases, we outlined the 
predisposing factors and putative prophylactic measures with comprehensive approaches to 
their management. 
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AEs during diagnostic vs therapeutic GI endoscopy 
 
Diagnostic GI endoscopy is generally safe. For upper GI endoscopy, the overall AEs and 
mortality rates were reported as 0,13% and 0,004% respectively, being 10 times higher for 
therapeutic interventions.
5
 General AEs in diagnostic colonoscopy ranges from 0,02% to 
0,07%.
6
 See table 1 which summarizes the frequencies, described in literature, of 
severe/emergent AEs. Considering the main complications under discussion, although there is 
no question about the emergent character of perforation, we are not able to discriminate the 
real severity of hemorrhage rates reported in literature; this fact is even more remarkable 
when looking for infection and embolization as a result of its rarity. 
 
Hemorrhage – is a rare in diagnostic procedures. In upper GI endoscopy, Mallory-Weiss tears 
cause bleeding in less than 0,5% when excessive retching and struggling occur, however those 
are not clinically significant.
7
 Globally, it may be more likely in individuals with 
thrombocytopenia and/or coagulopathy. Therefore, some authors recommend that diagnostic 
endoscopy can be performed when the platelet level is 20000/ml or greater and that a 
threshold of 50000/ml should be considered before performing biopsies.
3,8
   
 
Perforation – may occur in less than 0,04% of the diagnostic upper GI endoscopy, and is usually 
associated to operator inexperience and some patient-related risk factors, such as: cervical 
osteophytosis, Zenker’s or duodenal diverticulum, pharyngeal pouches, malignant/benign 
strictures and eosinophilic esophagitis.
9-12
 In colonoscopy the risk of perforation ranges from 
0,11% in diagnostic, up to 10% in therapeutic procedures.
6,13-15
 There are 3 main mechanisms 
for the occurrence: pneumatic/barotrauma, mechanical pressure, and post-therapeutic fragile 
wall. The patient-related risk factors contributing to perforation are well established and 
include: advanced age, female sex, diverticular disease, previous abdominal surgery, colonic 
strictures and therapeutic procedures.
13,16
 The main location is the rectosigmoid in more than 
2/3 of perforations.
16,17
  
 
Infection – is a rare AE that can result from the procedure itself (translocation or failure to 
follow guidelines for the reprocessing) and the use of endoscopic devices and accessories. 
Transient bacteremia has been reported at high rates, but the frequency of endocarditis or 
other clinical infections is extremely low.
18-20
 Antibiotic prophylactic regimens are only 
recommended for specific interventions and should be strictly followed: suspected incomplete 
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biliary drainage, puncture of fluid collections or cysts, percutaneous endoscopic feeding tube 
placement, and cirrhotic patients with upper GI bleeding.
21
 
 
Embolization – is mainly related to specific therapeutic interventions. Variceal sclerosis may 
cause extension of thrombus into the portal and mesenteric venous systems
22 
and 
cyanoacrylate injection has been reported as a cause of systemic emboli to lung, spleen and 
portal vein.
23,24
 ERCP-induced air embolism is extremely rare although severe fatal 
complications, causing immediate cardiopulmonary collapse has been reported.
 25
 
 
 
 
Specific therapeutic procedures 
 
Polypectomy 
The main AE in polypectomy is bleeding. Usually intra-procedure in gastric lesions, occurring in 
3,4% to 7,2% and delayed in duodenum, reported in 3,1% to 22% of patients.
2,26
 In colorectal 
polypectomy, bleeding occurs in 0,3% to 6,1%.
27
 Evidence that aspirin or NSAIDs increase the 
risk of bleeding after polypectomy is lacking. The reader is referred to guidelines concerning 
the management of anticoagulation and antiagregant therapy during endoscopy.
28
 The 
bleeding risk also depends on the type and the size of the polyp and the technique of 
polypectomy. Immediate bleeding can be prevented by the use of pure coagulation, 
epinephrine injection, clipping or endolooping the stalk, but no prophylactic measures have 
proved to be efficient in preventing delayed bleeding.
5
 
 
Endoscopic Mucosal Resection (EMR)/ Endoscopic Submucosal dissection (ESD)  
EMR (snare, cap, and ligature) is used to resect focal lesions of the mucosa up to the 
submucosal layer. The overall incidence of serious AEs such as bleeding, perforation and 
stricture was estimated to be between 0,5% and 5%.
29
 Bleeding occurs more often with 
multifocal EMR and gastric EMR, however delayed bleeding is rare (<5%) in these locations 
comparing to duodenum which rate is between 4% to 33%.
30
 It can be prevented by revision of 
the site of resection at the end of the procedure, coagulating any visible vessel, closing 
mucosal defects with clips and by therapy with proton pump inhibitor (PPI). Gastric EMR 
perforation is reported more frequently than in esophageal EMR, possibly because of greater 
lesions in the stomach.
31
 
In ESD AEs are similar to those described for EMR, although with greater frequency given the 
larger areas of resection. The overall incidence of bleeding and perforation with ESD is 11% 
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and 6% respectively.
32-34
 Due to the widespread acceptance of gastric and esophageal ESDs, 
the number of medical facilities that perform colorectal ESDs grew in recent years.
35,36
  The 
reported rate of perforation is 1,4-10,4% which is associated with large tumor size (>30mm) 
and the presence of fibrosis. In order to reduce the perforation rate for colorectal EDS, the use 
of specialized knives, distal attachments and hypertonic solutions, are necessary because of 
the thinner colonic wall.
35
 
 
Dilation 
The most common AEs related to dilation are perforation, haemorrhage, aspiration and 
bacteraemia. Aspiration of retained food and fluid can be an emergency, thus it should be 
prevented by prolonged fasting, suction, drainage, an anti-Trendelenburg position, or airway 
tube protection. Bleeding is usually self-limited. Despite the high frequency of bacteraemia, 
infectious sequelae are rare.
37,38
 Thus, perforation is the most relevant AE in dilation. 
In the esophagus, the risk of perforation in malignant, radiation-induced and post-caustic-
ingestion strictures is twice that of peptic strictures. Complex strictures (asymmetric, longer, 
<12mm in diameter) are also associated with increased rates of complications.
39
 Dilation of 
eosinophilic esophagitis is frequently associated with mucosal tears, but not perforation.
40
 
Although the wire-guided polyvinyl dilators and through-the-scope balloons have similar rates 
of efficacy and AEs, the operator’s experience level alters significantly the perforation risk.
9
 
Stepwise increase of balloon diameter may help reducing the risk. In achalasia, perforation 
rates up to 4% were described for pneumatic dilation. These rates may be reduced by starting 
with a 30 mm balloon, progressing only if symptoms do not improve and never using a balloon 
larger than 35 mm.
41
 Perforation rates in benign gastric outlet obstruction are high as 7,4%, 
risk factors are dilation in the setting of active ulceration and balloon size greater than 15 
mm.
42
 In lower gastrointestinal strictures’ dilation, mostly in anastomosis and in Crohn’s 
disease, the perforation is more often reported with 25 mm balloons.
43,44
  
 
Stenting 
Stents can be deployed in any part of the GI tract and are currently used for malignant, benign 
stenosis, and closing fistulas.
45
 Immediate AEs of esophageal self-expandable metal stents 
(SEMSs) occur in 2 to 12% of patients and include aspiration, pain, respiratory compromise and 
improper positioning. These AEs may be minimized by adequate patient preparation and 
positioning, familiarity with the stent, use of soft-tipped guide-wires, and avoidance of 
aggressive dilation.
46
 Late AEs occur in 20 to 40% of patients: regurgitation when the 
gastroesophageal junction is bridged, occlusion, migration and perforation. The risk of late 
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perforation and bleeding seems to be higher with larger stents, although larger stents 
decrease the rate of migration and tumor ingrowth.
47
 Pre-treatment with chemoradiotherapy 
was reported to increase the incidence of AEs by some authors, but not by others. 
Gastroduodenal stents are associated with similar AEs, and severe events as bleeding and 
perforation occur in 1 to 5% of patients.
48,49
 Also colonic stents have similar particularities; 
they are applied in acute malignant obstruction as bridge to surgery, with an high rate of 
clinical (6,9%) and silent (14%) perforation,
50
 and as long term palliation where perforation, 
and migration, have also been reported; bevacizumab therapy increases the risk of perforation 
in these cases.
51
 
 
Variceal ligation/sclerosis 
The overall AEs from endoscopic variceal sclerotherapy (EVS) have been estimated between 
35% and 78%, with a mortality rate of 1 to 5%.
52
 Significant immediate and delayed bleeding, 
stricture formation, perforation, systemic bacterial infection, or even portal thrombosis, were 
reported.
53
 However, endoscopic band ligation (EBL) was progressively considered the 
treatment of choice, with significant lower rates of AEs.
54,55
 Effective endoscopic treatment for 
gastric varices is still a sclerosant, properly the cyanoacrylate. Although considered relatively 
safe and effective, it is associated with systemic embolization, end-organ infarction, visceral 
fistula, abscess formation and bacteraemia.
23,24
 Recent studies highlight only 1% rate of severe 
complications, as embolization.
56
 It seems that the severity of AEs is related to pre-existing 
liver condition and infections complications.
57
 
 
Percutaneous endoscopic gastric and jejunal (PEG/PEJ) access 
Serious AEs occur in 1,5 to 9,4% of PEG procedures and include bleeding, injury of internal 
organs, perforation, “buried bumper syndrome”, wound infection, and necrotizing fasciitis.
58
 
Peristomal wound infections occur in 7 to 47% of patients receiving placebo in clinical trials, a 
single dose of cephalosporin or penicillin-based prophylaxis resulted in a significant 
reduction.
59
 Pneumoperitoneum is a benign and frequent occurrence. Bleeding from gastric or 
abdominal wall vessels is reported in less than 1% of procedures, it is important to reverse or 
held anticoagulants before. Prevention of injury to internal organs may be best achieved by 
ensuring adequate transillumination and finger indentation, and by use of the “safe-tract” 
technique. AEs associated with PEJ are similar to those of standard PEG placement, although 
their rate is higher.
60
 
 
Ablation techniques 
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Argon plasma coagulation (APC) is frequently used to treat vascular ectasia or for mucosal 
lesions ablation, as Barrett’s esophagus. Randomized trials report up to 4% of bleeding, 2% of 
esophageal perforation and 6% of stricture formation in esophagus.
61
 Colonic use of APC, can 
be associated with a rare but dreaded event - colon explosion - that may lead to perforation 
and emergency surgery. Meticulous full bowel cleansing with preparation without sugar 
compounds should be carried out before any APC in the colon.
62
 
Radiofrequency ablation (RFA) of Barrett’s epithelium has a relatively favourable profile. 
Bleeding requiring endoscopic therapy occur in less than 2% and strictures in 2 to 8%, 
perforation has also been reported.
63,64
 
 
Endoscopic submucosal tunnelling procedures  
Peroral Endoscopic Myotomy (POEM) and subepithelial lesions resection 
Common described complications include subcutaneous and mediastinal emphysema, 
pneumothorax, pneumoperitoneum, immediate or delayed haemorrhage, and infection. 
Caution should be taken when implementing these techniques. There are no specific 
recommendations until now.
65,66
 
 
Enteroscopy 
Enteroscopy using double-balloon (DBE), single-balloon or spiral enteroscopy have the 
potential for unique AEs. A meta-analysis of 9047 DBE found major AEs in 0,7% (perforation, 
pancreatitis, bleeding).
67
 The mechanisms of pancreatitis remain poorly understood, and the 
main way to prevent it is avoiding balloon inflation at duodenal level. The AEs rate is higher for 
therapeutic (4,3%) than for diagnostic DBE (0,8%). The rate of bleeding or perforation may be 
as high as 10,8% for patients undergoing polypectomy during DBE.
67,68
  
 
Endoscopic retrograde cholangiopancreatography (ERCP) 
ERCP is a demanding procedure associated with significant morbidity (6,85% of AEs) and 
occasional mortality (0,33%).
69-71
 AEs can be divided into general (in common with upper GI 
endoscopy) and specifically related to bilio-pancreatic handling (bleeding, perforation, 
infection and pancreatitis). Factors modulating the risk of complications are the indication for 
ERCP and type of intervention, case-volume of operator, age and co-morbidities of the 
patient.
72
 Pancreatitis is the most prevalent cause of morbidity and mortality after ERCP, but it 
will not be discussed in this issue. 
Bleeding is mainly linked to sphincterotomy and in half of the cases is recognized 
immediately.
69
 Clinically significant haemorrhage occurs in 0,1% to 2% of sphincterotomies. It 
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can be attenuated by identifying patients at risk and adapting the sphincterotomy technique, 
limiting pure-cut current, using endocut mode or balloon sphincteroplasty, according to 
situations. 
Perforation occurs in 0,6% of procedures, with an estimated mortality rate of 0,06%,
69
  
however delayed diagnosis and intervention increase mortality up to 23%. The most 
commonly used classification of ERCP-induced perforation was suggested by Stapfer et al. 
according to that, perforations can be categorized into four types. Bowel perforation is more 
frequent in patients with Billroth II gastrectomy or Roux-en-Y operation, duodenal stricture, 
parapapilar diverticulum, while sphincterotomy perforation is more common during needle 
knife precut.
25,73
 It can be prevented by ensuring the correct orientation of the cutting wire 
during sphincterectomy, following a step-by-step incision, tailoring the size of the papilla and 
bile ducts, and using balloon dilation of the papilla after a small sphincterotomy in cases of 
large stones.
5
  
Cholangitis and cholecystitis are potential infectious AEs. Risk factors for cholangitis are failed 
or incomplete biliary drainage or combined percutaneous-endoscopic procedures.
70
 
Prophylactic antibiotics can reduce the rate of bacteraemia but few studies showed a 
reduction in clinical sepsis.
74
 Therefore the main recommendation regarding prevention and 
treatment of cholangitis is successful and complete biliary drainage. Post-ERCP acute 
cholecystitis has an incidence rate of <0,5% and can be related to the non-sterile introduction 
of contrast medium. The use of cleaned and disinfected scopes, sterile contrast medium and 
temporary bile duct drainage when definitive drainage cannot be achieved are required. 
Antibiotic prophylaxis has proven to be effective in patients at risk for infective endocarditis, in 
patients with pancreatic pseudocyst and in patients with cholestasis or enlarged bile ducts.
5
 
ERCP-induced air embolism is a rare but severe complication
25
 that possibly occurs due to 
sphincterotomy or high intra-mural pressure of insuflated air, disrupting the gastrointestinal or 
hepatobiliary structure and creating connection to the veins in the duodenal walls. Other 
reported mechanisms include portal vein puncture due to guide-wire cannulation and 
erroneous placement of nasobiliary drainage tube to the portal vein.
75,76
  Special care should 
be taken for possible air embolism in relation to the recent wide application of peroral 
cholangioscopy.
77
 Other potential very rare complications are splenic injury, hepatic 
hematoma, pneumothorax and basket impactation.
25
 
 
Endoscopic ultrasound (EUS) 
The non-interventional diagnostic EUS AEs rate of 0,03% to 0,15% is comparable to that of 
upper GI diagnostic endoscopy. Although due to specific mechanical and optical properties of 
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echoendoscopes, the risk of esophageal or duodenal perforation seems somewhat higher. 
Patients undergoing EUS-fine needle biopsy (EUS-FNB) are approximately ten times more likely 
to develop AEs.
78
 In a recent systematic review the overall complication rate and mortality was 
0.98% and 0,02% respectively. Significant AEs were acute pancreatitis (34%), fever and 
infectious complications (16%), bleeding (13%) and perforation or bile/pancreatic leaks (3%). 
Serious infections were described in published reports following biopsy of mediastinal lymph 
nodes, cystic lesions, ascitis or pleural fluid.
78
 Antibiotic prophylaxis should be administered in 
patients undergoing EUS-FNB of cystic lesions and fluid collections.
79
 Self-limited mild 
intraluminal bleeding was reported in up to 4% and extraluminal bleeding in 1,3% of cases, the 
last can be visualized clearly by EUS.
80
 Patients with highly vascularized lesions (mesenchymal, 
neuroendocrine tumors, and some metastases) and cystic lesions may be at greater risk.
78
 
According to guidelines, EUS-FNB of solid masses and lymph nodes may be performed in 
patients taking acetyl salicylic acid (ASA) or NSAIDs, but not in patients receiving other 
anticoagulant or antiagregant drugs. However, EUS-FNB of cystic lesions should be avoided in 
patients taking any antiplatelet agent.
28,81
 
At this moment, EUS is an increasing reference for a range of therapeutic procedures with 
specific complications risk, as drainage of pancreatic pseudocysts, abscess and necrosis 
debridement,
82,83 
celiac plexus neurolysis,
84
 biliary drainage,
85
 or even research vascular 
procedures.
86
 
 
Detection and management of the two main emergencies 
 
Hemorrhage 
Bleeding during therapeutic endoscopy can be part of the procedure, especially during 
polypectomies, EMR or ESD.
5
 Immediate and late bleeding (by definition is hematemesis 
and/or melena or hemoglobin drop >2 g)
1
 can be controlled with conventional hemostatic 
tools (figure 1), under simultaneous attention to resuscitation and conservative management. 
Reader is referred to the chapter of acute non-variceal bleeding in this volume. 
Patients with upper GI resection of tumoral lesions should be treated with intravenous PPI as 
for Forrest IIa ulcers:
5
 High-dose PPI therapy improves healing rates and reduces the risk of 
delayed bleeding.
33
 There are small successful series of over-the-scope-clips (OTSC) use in 
acute GI bleeding unresponsive to conventional methods, which is becoming a consistent 
approach.
87
 The hemospray, a highly absortive powder that when in contact with blood 
becomes cohesive and forms a stable mechanical plug, is also a promising hemostatic agent as 
demonstrated in early studies.
88
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Also in post-sphincterotomy bleeding, the first line treatment is injection of dilute epinephrine. 
Ballon-tamponade using standard dilating balloons for temporary control of bleeding and 
improve visualization of the bleeding point. Thermal therapy or placement of clips can follow 
the initial measures. Caution should be taken to avoid thermal injury or clip closure over the 
pancreatic sphincter.
74
 Self-expandable metal stents have also been used as a rescue 
technique if other methods fail.
89
 Very rarely, angiography or surgery is required for refractory 
bleeding. 
 
Perforation 
Luminal perforation still is the most feared AEs of GI endoscopy, even after some advances and 
demystification brought by natural orifices transluminal endoscopic surgery (NOTES). The 
rationale for that is multifactorial.
1,90
 A recent review by Baron et al. pointed out some main 
commandments of acute endoscopic perforation: 1) prompt recognition (preferably during the 
procedure) is essential to improve outcome; 2) extraluminal air does not automatically mean 
the need for surgery as it is not infectious and is not necessarily proportional to the size of the 
perforation; 3) extraluminal air under pressure is a medical emergency; 4) residual 
extraluminal air may persist without clinical significance; 5) perforations tend to close after 
drainage or diversion of luminal contents; 6) failed endoscopic closure generally requires 
surgical intervention. 
 
General approach 
In therapeutic procedures is very important a final careful examination, in this case diagnosis 
or suspicious is frequently immediate and allows prompt closure attempt. In certain 
circumstances symptoms may be masked, as in sedated or elderly patients with multiple 
comorbidities, small perforations, or in case of transmural burn syndrome with progressive 
wall fragility. Whenever there is a clinical deterioration hours after an endoscopic procedure, 
delayed perforation should be considered. Late recognition may be from 1 hour to several 
weeks later. Clinical suspicious should be heightened in the presence of ongoing abdominal 
distension/pain, chest pain, shortness of breath, subcutaneous emphysema or fever.
91
 Once 
suspected, besides closure attempt, immediate general measures should take place, as 
administration of intravenous broad-spectrum antibiotics, vital signs motorization, blood tests, 
surgeon contact and counseling, placement of a nasogastric tube (except in esophageal 
perforation, because it may exit the perforated site), and cessation of oral intake. At the same 
time, if periprocedure perforation, switch as much as possible to CO2 insufflation. If 
perforation is suspected later, an initial imaging assessment should include a chest and 
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flat/upright abdominal radiography, if unrevealing computerized tomography CT with water-
soluble contrast (orally, via nasogastric or nasoduodenal tube, or per rectum) may show 
contained or free contrast material extravasation. Endoscopic closure should then be 
attempted if feasible (figures 2 and 3).
5,90,92
  
 
An essential and lifesaving attitude is emergent decompression when extraluminal air is under 
pressure. Tension pneumothorax requires immediate needle catheter inserted along the 
midclavicular line in the second intercostal space of the affected side. Then a chest tube should 
be placed. Subcutaneous emphysema usually resolve spontaneously, however attention 
should be given when massive air is tracking into soft tissues of the neck as it can result in 
airway obstruction, needing endotracheal intubation. Avoid abdominal compartment 
syndrome (drop in blood-pressure levels, related to a decreased cardiac preload caused by 
peritoneal hypertension) in tension pneumoperitoneum, with a 18 or 20 gauge trocar needle 
in either lower abdominal quadrants, just at or inferior to the umbilicus. The needle should be 
removed but the plastic sheath is left in situ to allow continuous decompression of the 
peritoneal cavity, while the procedure resumes and endoscopic intervention is ongoing even 
under air insufflation (figure 4).
5,90,93
 
 
Endoscopic closure methods 
Endoscopic closure methods include clips, stents and suturing devices. Its selection relies on 
defect location, dimension and conformation, occurrence situation, equipment availability and 
operator preference. Through-the-scope endoclips (QuickClip - Olympus®, Resolution Clip – 
Boston Scientific®, Tri-clip – Cook Medical®) are the most used and currently the standard 
method for endoscopic closure of perforations.
94
 It has been suggested that for defects smaller 
than the width of the open clip it should be clipped in a “side to center” manner; when the 
defect is slightly larger than the width of the open clip, the diameter can be reduced by air 
suction. In case of large defects, the first clip is the most critical and a recent proposal for 
certain cases is to perform small incisions around to provide a better grip for the clip.
95 
Combined methods are also a good approach for larger defects, for instances, hemoclips plus 
Endoloop,
96,97
 plus omental patch
93
 or plus band ligation.
98 
 OTSC system, initially developed for 
hemostasis, but extensively explored for ‘otomies’ closure in NOTES
99
 are ultimately applied in 
perforation’s closure, using or not specific grasping or anchoring devices to approximate 
margins before clip release.  Stents are an alternative method (fully or partially covered metal 
stents and plastic stents) for luminal diversion, mainly in esophageal malignant rupture. Stents 
can also be used in benign perforation, and removed 4 to 12 weeks later. Several endoscopic 
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suturing prototypes were developed in the context of NOTES, anti-reflux and bariatric 
procedures
90,100
 namely: T-tags (Ethicon endo-Surgery and Cook Endoscopy), Overstitch (Apollo 
Endosurgery), pursed-string-suturing device (LSI Solutions), flexible endostitch (Covidien), NDO 
plicator (NDOSurgicalInc), flexible stapler (Power Medical Interventions), nevertheless its 
application remains limited in humans, and some of them only tested in animal models.  
 
Location particularities  
In esophagus, non-surgical treatment is indicated only in highly well selected.
101
 Primary repair 
is feasible if without intrinsic esophageal disease, absence of sepsis, and especially when the 
time interval is less than 24h.
102
 Endoscopic stenting represents a successful treatment option 
in perforated non-resectable esophageal malignancy. In cases of benign rupture, the stent 
placement for a period of 5-6 weeks is effective in 76% of patients, with no significant 
difference between stents.
103
 Nevertheless, complication rate can be as high as 20 to 72%, thus 
the stent choice should depend on expected risk of stent migration (mostly with fully covered 
SEMSs, and less frequent in presence of any stricture) and to a minor degree, on expected risk 
of tissue in- or overgrowth (mostly with partially covered SMESs). In this situation a fully 
covered stent of the same diameter can be placed inside (stent-in-stent method) allowing 
uneventful removal of both after 10-14 days. This can also be precluded with the initial 
application of large diameters fully covered stents (22-23 in the body).
103
 Finally, standard 
through-the-scope clips are successful in the closure of perforations up to 12 mm, in a pooled 
analysis where the median healing time was 18 days.
104
 Vacuum-assisted therapy is also a 
possible technique.
105
 OTSC brings technical difficulties in esophageal application because of 
narrow lumen and oblique orientation.
106
 
In gastric perforations, the main closure approach is endocliping alone or in combination, 
which can achieve 98% of success if immediate diagnosis.
93
 Shi et al. described a new 
combination technique of metallic clips and endoloops as interrupted suture after endoscopic 
full-thickness resection of gastric submucosal tumors in 20 patients;
97
 when the defect is large 
(25 mm) it can as well be managed by  the omental-patch method or the OTSC system.
93,106
 
In ERCP-related duodenal perforations, different approaches are made according to the type 
and the severity of the leak and clinical manifestations.
107
 In type I and type II perforations, 
surgical treatment was generally recommended, although recent successful reports of 
endoscopic closure with endoclips,
108
 combined clips and endoloops or OTSC were 
published;
109
 particularly in type II perforations, self-expandable metal stents seems to be 
effective.
110
 Type III and IV perforations tend to be a controlled retroperitoneal perforation; in 
case of leak with fluid collection, the recognizing and quick plastic stents placing for 
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appropriate drainage, associated with antibiotics are essential.
107
 In retroperitoneal 
perforations, 87.9% of patients recovered with  conservative treatment (total mortality was 
2.9%), and 80.8% of patients with free air peritoneal perforations received surgery (total 
mortality was 24.7%). 
Small bowel enteroscopy related perforations often lead to surgical management. 
In colon perforations, endoscopic closure in association with conservative management is 
successful in 60-100% of patients, avoiding the morbidity of surgery and shortening the length 
of hospital stay, provided that perforation is immediately recognized and closed. Initial series 
showed success with endoclips for small perforations,
111,112
 in absence of peritoneal irritation. 
Subsequently also diagnostic, large perforations, in the presence of free air or moderately 
inflammatory signs, were also successfully treated with multiple clipping, OTSC or even band 
ligation.
90
 Bowel preparation status is in general an important factor that may influence clinical 
management.  In delayed recognition, clipping should be considered only if the patient is 
stable and a specific site is highly suspected, mainly in rectosigmoid location.
112
 When 
comparing therapeutic and diagnostic colonoscopy-associated perforation, the former are 
usually larger, irregular and sometimes not immediately recognized in terms of location, thus 
they are more prompt for surgical approach.
113
 Surgery is indicated in patients with large 
perforations, generalized peritonitis or ongoing sepsis as well as in patients with concomitant 
pathology, such as a large sessile polyp likely to be a carcinoma, unremitting colitis, or 
obstructing colonic lesion. Although rare, extraperitoneal colonic perforation (subcutaneous 
emphysema, pneumoretroperitoneum, pneumomediastinum, pneumopericardium) should be 
managed conservatively, and the air is commonly reabsorbed within 72 hours.
114
 In rectum, 
located below the peritoneal reflection air leakage can develop through next or distal soft 
tissues. Penetration to perirectal tissue is a better designation and is treated with broad 
spectrum antibiotics and nothing by mouth even though endoscopic clips can also be applied.
90
 
 
In all these cases a coordinated surveillance by the surgical and medical team is essential in the 
first 48 hours. In case of no improvement or any sign of deterioration, surgery should be 
considered in a case-by-case decision. 
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Conclusion 
Endoscopic complications are a pertinent feature of patient care that has been receiving great 
attention, due to increased technical advances and complexity of therapeutic endoscopy. 
Three main factors contribute to endoscopic adverse events - patient, operator, and type of 
procedure. Thus a comprehensive knowledge of the techniques and materials, experience 
acquisition and maintenance in specific procedures, standardization of treatments and training 
are important issues for prevention of AEs. When facing an AE, early recognition and prompt 
approach by endoscopic or multidisciplinary management, are essential for a successful 
outcome. No rule suits all, hence endoscopic complication approach must be customized to 
individual patients.  
 
Practice points 
 
• Adverse event (AE) is a situation that prevents completion of the planned procedure. 
• Be prepared for the endoscopic procedure and furthermore its possible AEs – 
theoretical knowledge, equipment, team, and environment conditions. 
• According to indications prevent infection and bleeding risk. 
• Early recognition is a determining factor of the general outcome results. 
• Bleeding (early and delayed) is usually controlled by endoscopic hemostasis. 
• In perforation, an endoscopic plus conservative treatment, under multidisciplinary 
surveillance should always be attempted, if possible. 
• Emergent needle decompression is an essential and lifesaving attitude when 
extraluminal air is under tension. 
• Review AEs as part of continuing quality improvement. 
 
Research agenda 
 
• Multicenter studies to define associated risk factors of AEs for each newly-introduced 
procedure. 
• Comparative studies between the newly appearing tools for hemostasis and closure. 
• Effective, user-friendly and cheaper suture devices for endoscopy. 
• Safer tools for endoluminal dissection (knifes and coagulation graspers). 
• Increment biodegradable tools - protective plug, spray and stents. 
• Image fusion systems for safer approach in more aggressive procedures. 
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Legends  
 
Table 1. Available frequencies of severe/emergent AEs (%).  
ESD – endoscopic submucosal dissection; APC – argon plasma coagulation; RFA – 
radiofrequency; FNB – fine needle biopsy. *Infection – rates resolved under adequate 
antibiotic prophylaxis for specific procedures. 
 
Figure 1. Management of post-endoscopic procedures’ bleeding. 
 
Figure 2. Management of upper GI perforations  
(Adapted from Blero D, Devière J. Nat Rev Gastroenterol Hepatol. 2012)  
 
Figure 3. Management of lower GI perforations  
(Adapted from Blero D, Devière J. Nat Rev Gastroenterol Hepatol. 2012) 
 
Figure 4. Acute decompression of tension pneumothorax and pneumoperitoneum. 
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Table 1 
 
 Hemorrhage Perforation Infection* Embolization 
Diagnostic GI Endoscopy     
Upper GI  0,002-0,06 0,0009-0,04 - - 
Colonoscopy 0-0,03 0,005-0,2 - - 
Therapeutic Procedures     
Polipectomy (upper/lower) 3,4-10,0 / 0,26-6,1 0,06-1,1 - - 
ESD (upper/lower) 1,8-15,6 / 0-12,0 1,3-4,0 / 1,4-10,4 - - 
Stenting (upper/lower) 0-3,9 0-0,8 / 3,8-10,0 - - 
Dilation  - 0-4,0 - - 
Gastrostomy (jejunostomy) 0-1,0 - 7,0-47,0 - 
Variceal ligation / sclerosis  0-0,7 / 2,0-5,0 - 0-1,0 
APC / RFA ablation 0-4,0 / 0-2,0 0-2,0  - - 
Enteroscopy     
Diagnostic 0-0,8 0-0,3 - - 
Therapeutic 0-3,0 0-4,0 - - 
ERCP     
Diagnostic 0 0,11 - - 
Therapeutic 0,49-2,0 0,3-0,8 0,5-3,0 rare reports 
EUS     
Diagnostic plus FNB 0,15-3,7 0,03-0,86 0-16,0 - 
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Bleeding
Polipectomy
Injection of Epinephrine solution – vision improvement
(volume tamponade , vasoconstrictor) 
Clips – endoclips / OTSC 
Endoloop
Band ligature
Post-procedure , up to 30 daysImmediate
EMR /ESD Sphincterotomy “Ulcer bed”
Usually visible vessel:
Coagulation grasper
Coagulation with ESD-knife
Clip – may jeopardize the
procedure finishing, 
consider only at the end. 
Balloon tamponade
Thermal or mechanical tools
Away from pancreatic duct
High-risk stigmata, add any:
Mechanical method – clips
Thermal – cautery, APC
Injectable – sclerosants, 
trombin/fibrin glue
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Perioperative diagnosis
Shift to CO2 insuflation
Broad spectrum antibiotics
Attempt endoscopic closure – clips, stents, …
Lab tests (CBC, INR, LFTs) and ECG
Surgeon counseling
Abdominal and chest CT with oral water-soluble contrast
(NG tube if stomach, right decubitus if duodenal perforation)
Large or persistent leak No leakage (covered perforation)
Repeat endoscopic attempt or surgery
Favorable clinical outcome (<48h): 
resume feeding if contrast swoallow normal
Continue conservative treatment
Unfavorable outcome (<48h): 
consider surgery
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Diagnosis or Suspicion of Perforation
Shift to CO2 insuflation
Consider percutaneous needle
Attempt endoscopic closure – clips
Broad spectrum antibiotics
Lab tests (CBC, INR, LFTs) and EKG
Surgeon conseling
Abdominal CT with rectal contrast
Large or persistent leak No leakage (covered perforation)
Repeat endoscopic attempt or surgery
Favorable clinical outcome (<48h): 
resume feeding
Continue consevative treatment
Unfavorable outcome (<48h): 
consider surgery
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Figure 4
